avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb5 | mm10_v2_chr11_+_96302595_96302595 | 0.55 | 4.8e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_121636173 Show fit | 14.65 |
ENSMUST00000032203.7
|
alpha-2-macroglobulin |
|
chr11_+_74619594 Show fit | 9.62 |
ENSMUST00000100866.2
|
RIKEN cDNA E130309D14 gene |
|
chr7_+_143005046 Show fit | 7.63 |
ENSMUST00000009396.6
|
tetraspanin 32 |
|
chr7_+_143005770 Show fit | 7.10 |
ENSMUST00000143512.1
|
tetraspanin 32 |
|
chr19_-_45816007 Show fit | 7.10 |
ENSMUST00000079431.3
ENSMUST00000026247.6 ENSMUST00000162528.2 |
Kv channel-interacting protein 2 |
|
chr7_+_143005677 Show fit | 6.97 |
ENSMUST00000082008.5
ENSMUST00000105925.1 ENSMUST00000105924.1 |
tetraspanin 32 |
|
chr7_+_143005638 Show fit | 6.77 |
ENSMUST00000075172.5
ENSMUST00000105923.1 |
tetraspanin 32 |
|
chr6_+_145121727 Show fit | 4.82 |
ENSMUST00000032396.6
|
lymphoid-restricted membrane protein |
|
chrX_+_8271642 Show fit | 4.81 |
ENSMUST00000115590.1
|
solute carrier family 38, member 5 |
|
chr2_-_164743182 Show fit | 4.23 |
ENSMUST00000103096.3
|
WAP four-disulfide core domain 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 28.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.9 | 14.6 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.3 | 8.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.7 | 7.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.4 | 7.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 5.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 5.0 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
1.2 | 4.8 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.3 | 4.8 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 4.7 | GO:0007338 | single fertilization(GO:0007338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 28.5 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.1 | 10.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 9.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 7.6 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 7.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 5.9 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 3.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 2.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 2.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.7 | GO:0001726 | ruffle(GO:0001726) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 14.6 | GO:0043120 | interleukin-8 binding(GO:0019959) tumor necrosis factor binding(GO:0043120) |
1.9 | 9.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 9.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.8 | 4.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.3 | 4.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 4.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 4.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 4.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 4.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 4.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 8.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 2.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 2.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 14.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 9.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 4.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 4.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 4.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 3.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 2.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 2.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |